Skip to content

Incyte

US · INCY #803 by market cap Listed 1970
114.63 -1.25 -1.07%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 117.09 +1.05%
After-hours 114.63 0.00%
Overnight 116.00 +0.11%
129.9392.24114.632026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on INCY?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +1.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 5.2% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 58.5x Better than 8%
Forward P/E 22.4x Better than 30%
Price / Sales 4.1x Better than 29%
P/E vs own 5-yr range 80th pctl Better than 27%
Growth A-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 14.8% Better than 75%
Net income CAGR (3Y) 55.7% Better than 89%
Free cash flow CAGR (3Y) 14.2% Better than 58%
Profitability A+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 92.8% Better than 97%
Operating margin 26.1% Better than 86%
Net margin 25.0% Better than 85%
Return on equity 29.9% Better than 87%
Return on invested capital 27.7% Better than 95%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -10.3% Better than 50%
6-month return 18.0% Better than 81%
12-month return (ex latest month) 14.6% Better than 52%
Distance below 52-week high 13.6% Better than 75%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.3x Better than 76%
Debt to assets 0.6% Better than 95%
Interest coverage 686.5x Better than 98%
Free cash flow / net income 103.3% Better than 40%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 55.6% Better than 33%
Upside to average target 19.3% Better than 31%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -5.25%
1M -1.71%
3M -9.90%
6M +18.07%
YTD +16.05%
1Y +12.64%
3Y +109.51%
5Y +77.69%

Key statistics

Price & volume

Prev close
115.87
Open
116.85
Day range
114.28 - 117.51
Avg price
115.24
Volume
1.54M
Turnover
177.16M
Amplitude
2.79%
52-week range
89.25 - 132.60

Valuation

P/E
17.88
P/E (TTM)
58.48
P/B
4.14
EPS
6.41
Net profit
1.31B
Net assets
5.64B

Share structure

Market cap
23.36B
Float cap
19.70B
Shares out
203.83M
Float shares
171.89M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 59% of range
89.25 132.60

13.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+11.86M net over the window

Short interest

Shares short
10.65M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Incyte (INCY)?

Incyte last traded at 114.63. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Incyte's market cap?

About 23.36B.

What is the P/E ratio of Incyte?

The trailing twelve-month P/E is 58.48, below its own 5-year average of 107.24 — toward the top of its historical range (79.92% percentile). See the Valuation tab for the full history.

Does Incyte pay a dividend?

Incyte does not currently pay a regular dividend.

Is Incyte a buy according to analysts?

The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 136.76, which implies 19.3% upside from the current price. This is not investment advice.

What is Incyte's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Incyte a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.

Incyte discussion 0 comments

Add a comment